Ottobock SE & Co KgaA

Ottobock's capital structure is characterized by a debt-to-equity ratio of 2.69, indicating a significant reliance on debt financing. The company's liquidity position is moderate, with a current ratio of 0.95 and only 90.4 million EUR in cash and equivalents, which is insufficient to cover its 1.05 billion EUR in long-term debt. This suggests a potential liquidity risk if short-term obligations exceed available cash. In terms of profitability, Ottobock's return on equity (ROE) of 23.12% is strong, outperforming the typical industry benchmark for ROE in the medical equipment sector. However, its return on assets (ROA) of 4.4% is in line with the industry median, indicating that the company is not generating exceptional returns relative to its asset base. Gross profit of 886.5 million EUR and operating income of 199.8 million EUR reflect a healthy margin structure, but the net income of 90.2 million EUR suggests that interest and other expenses are consuming a significant portion of operating profits. Geographically, Ottobock's revenue is not disclosed by segment or region in the available data, but the company operates globally in the medical equipment and supplies market. The lack of detailed geographic breakdown limits the ability to assess exposure to specific markets or regions. The company's revenue concentration is not explicitly stated, but the absence of segment-specific data implies a need for further investigation into potential overreliance on a single market or product line. Ottobock's growth trajectory is not explicitly outlined in the available data, but the company's operating cash flow of 332.7 million EUR and free cash flow of 117.9 million EUR suggest a capacity to fund operations and potentially reinvest in the business. Capital expenditures of -108.7 million EUR indicate that the company is investing in its infrastructure, which could support future growth. Analysts have provided a mean price target of 81.25 EUR and a median price target of 83.00 EUR, with a mean recommendation of 1.75, indicating a generally positive outlook. The risk assessment for Ottobock highlights a medium liquidity risk and a low dilution risk. The company's net cash position is negative after accounting for total debt, which could pose a challenge in maintaining liquidity if cash flow from operations is disrupted. There is no indication of dilution risk in the near term, as the number of shares outstanding has not changed between basic and diluted shares. Recent events and filings have not been disclosed in the available data, so the impact of any recent developments on Ottobock's financial position or strategic direction cannot be assessed.